Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta -Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020)
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting of systematic reviews of studies testing Chinese Herbal Medicines (CHM) interventions. |
| Full bibliographic reference | Zhang X, Tan R, Lam WC, Yao L, Wang X, Cheng CW, Liu F, Chan JC, Aixinjueluo Q, Lau CT, Chen Y, Yang K, Wu T, Lyu A, Bian Z. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020). Am J Chin Med. 2020;48(6):1279-1313. |
| Language | English |
| PubMed ID | 32907365 |
| Reporting guideline acronym | PRISMA-CHM 2020 |
| Study design | Systematic reviews/Meta-analyses/Reviews/HTA/Overviews |
| Clinical area | Complementary and alternative medicine |
| Applies to the whole report or to individual sections of the report? | Whole report |
| Record last updated on | November 19, 2020 |